Evidence map›Paper›PMID 37408865›Full record

ArticleClinical epidemiology2023

Is Age the Most Important Risk Factor in COVID-19 Patients? The Relevance of Comorbidity Burden: A Retrospective Analysis of 10,551 Hospitalizations.

Damià Valero-Bover, David Monterde, Gerard Carot-Sans, Miguel Cainzos-Achirica, Josep Comin-Colet, Emili Vela, Montse Clèries, Júlia Folguera, Sònia Abilleira, Miquel Arrufat and 7 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Damià Valero-BoverCatalan Health Service, Barcelona, Spain.
David MonterdeDigitalization for the Sustainability of the Healthcare System (DS3) - Institut d'Investigacions Biomèdiques de Bellvitge (IDIBELL), Barcelona, Spain.ORCID 0000-0001-5362-0455
Gerard Carot-SansCatalan Health Service, Barcelona, Spain.ORCID 0000-0001-5982-7975
Miguel Cainzos-AchiricaCenter for Outcomes Research, Houston Methodist, Houston, TX, USA.
Josep Comin-ColetCardiology Department, Bellvitge University Hospital (IDIBELL), Barcelona, Spain.ORCID 0000-0001-8780-720X
Emili VelaCatalan Health Service, Barcelona, Spain.
Montse ClèriesCatalan Health Service, Barcelona, Spain.
Júlia FolgueraCatalan Health Service, Barcelona, Spain.ORCID 0000-0002-2519-0053
Sònia AbilleiraCIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.ORCID 0000-0002-5587-128X
Miquel ArrufatCatalan Institute of Health, Barcelona, Spain.ORCID 0000-0002-8752-9112
Yolanda LejardiCatalan Institute of Health, Barcelona, Spain.
Òscar SolansDigitalization for the Sustainability of the Healthcare System (DS3) - Institut d'Investigacions Biomèdiques de Bellvitge (IDIBELL), Barcelona, Spain.
Toni DedeuWHO European Centre for Primary Health Care, Almaty, Kazakhstan.
Marc CocaCatalan Health Service, Barcelona, Spain.
Pol Pérez-SustCatalan Health Service, Barcelona, Spain.ORCID 0000-0003-2073-0951
Caridad PontesCatalan Health Service, Barcelona, Spain.ORCID 0000-0002-3274-6048
Jordi Piera-JiménezCatalan Health Service, Barcelona, Spain.ORCID 0000-0001-6471-9979
Institut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ESCatalan Society of Family and Community Medicine · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESGlobal Health Research Center of Central Asia · KZHouston Methodist · USUniversitat Autònoma de Barcelona · ESUniversitat Oberta de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the contribution of age and comorbidity to the risk of critical illness in hospitalized COVID-19 patients using increasingly exhaustive tools for measuring comorbidity burden. Patients and Methods: We assessed the effect of age and comorbidity burden in a retrospective, multicenter cohort of patients hospitalized due to COVID-19 in Catalonia (North-East Spain) between March 1, 2020, and January 31, 2022. Vaccinated individuals and those admitted within the first of the six COVID-19 epidemic waves were excluded from the primary analysis but were included in secondary analyses. The primary outcome was critical illness, defined as the need for invasive mechanical ventilation, transfer to the intensive care unit (ICU), or in-hospital death. Explanatory variables included age, sex, and four summary measures of comorbidity burden on admission extracted from three indices: the Charlson index (17 diagnostic group codes), the Elixhauser index and count (31 diagnostic group codes), and the Queralt DxS index (3145 diagnostic group codes). All models were adjusted by wave and center. The proportion of the effect of age attributable to comorbidity burden was assessed using a causal mediation analysis. Results: The primary analysis included 10,551 hospitalizations due to COVID-19; of them, 3632 (34.4%) experienced critical illness. The frequency of critical illness increased with age and comorbidity burden on admission, irrespective of the measure used. In multivariate analyses, the effect size of age decreased with the number of diagnoses considered to estimate comorbidity burden. When adjusting for the Queralt DxS index, age showed a minimal contribution to critical illness; according to the causal mediation analysis, comorbidity burden on admission explained the 98.2% (95% CI 84.1-117.1%) of the observed effect of age on critical illness. Conclusion: Comorbidity burden (when measured exhaustively) explains better than chronological age the increased risk of critical illness observed in patients hospitalized with COVID-19.

Indexed as

case-mix toolcomorbiditiescomorbidity burdenCOVID-19hospitalized patientsrisk assessment

Identifiers

PMID37408865
PMCPMC10319286
OpenAlexW4382602076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.